Drug Interactions Database

1418 interactions from BNF 85 - Check your medicines

Source: BNF 85
tetracyclines lithium

increases risk of lithiumtoxicity

Moderate Anecdotal
theophylline lithium

decreases concentration

Moderate Anecdotal
thyroidhormones digoxin

affects concentration

Moderate Theoretical
ticagrelor dabigatran

increases exposure

Moderate Study
ticagrelor thrombininhibitors

increases exposure

Moderate Study
tocilizumab alprazolam

decreases exposure

Moderate Theoretical
tocilizumab aminophylline

decreases exposure

Moderate Theoretical
tocilizumab antiepileptics

decreases exposure

Moderate Theoretical
tocilizumab atorvastatin

decreases exposure

Moderate Study
tocilizumab benzodiazepines

decreases exposure

Moderate Theoretical
tocilizumab calciumchannelblockers

decreases exposure

Moderate Theoretical
tocilizumab ciclosporin

decreases exposure

Moderate Theoretical
tocilizumab corticosteroids

decreases exposure

Moderate Theoretical
tocilizumab coumarins

decreases exposure

Moderate Theoretical
tocilizumab dexamethasone

decreases exposure

Moderate Theoretical
tocilizumab diazepam

decreases exposure

Moderate Theoretical
tocilizumab fosphenytoin

decreases exposure

Moderate Theoretical
tocilizumab methylprednisolone

decreases exposure

Moderate Theoretical
tocilizumab midazolam

decreases exposure

Moderate Theoretical
tocilizumab phenytoin

decreases exposure

Moderate Theoretical
tocilizumab simvastatin

decreases exposure

Moderate Study
tocilizumab statins

decreases exposure

Moderate Study
tocilizumab theophylline

decreases exposure

Moderate Theoretical
tocilizumab warfarin

decreases exposure

Moderate Theoretical
tolcapone levodopa

increases exposure

Moderate Study
trimethoprim dopaminereceptoragonists

increases exposure

Moderate Study
trimethoprim pramipexole

increases exposure

Moderate Study
trimethoprim treprostinil

increases exposure

Moderate Theoretical
tucatinib alfentanil

increases exposure

Moderate Theoretical
tucatinib aliskiren

increases exposure

Moderate Theoretical
tucatinib antihistamines,non-sedating

increases exposure

Moderate Theoretical
tucatinib benzodiazepines

increases exposure

Moderate Study
tucatinib buspirone

increases exposure

Moderate Theoretical
tucatinib colchicine

increases exposure

Moderate Theoretical
tucatinib dabigatran

increases exposure

Moderate Theoretical
tucatinib darifenacin

increases exposure

Moderate Theoretical
tucatinib digoxin

increases exposure

Moderate Study
tucatinib docetaxel

increases exposure

Moderate Theoretical
tucatinib edoxaban

increases exposure

Moderate Theoretical
tucatinib everolimus

increases exposure

Moderate Theoretical
tucatinib fexofenadine

increases exposure

Moderate Theoretical
tucatinib ibrutinib

increases exposure

Moderate Theoretical
tucatinib lomitapide

increases exposure

Moderate Theoretical
tucatinib loperamide

increases exposure

Moderate Theoretical
tucatinib midazolam

increases exposure

Moderate Study
tucatinib naloxegol

increases exposure

Moderate Theoretical
tucatinib opioids

increases exposure

Moderate Theoretical
tucatinib paclitaxel

increases exposure

Moderate Theoretical
tucatinib rivaroxaban

increases exposure

Moderate Theoretical
tucatinib simvastatin

increases exposure

Moderate Theoretical
Important: This database uses data from the British National Formulary (BNF 85). It is for informational purposes only and is not a substitute for professional medical advice.